Oldip HCT Tablet 5/40/12.5 mg

Adult dose

This medication should be taken once daily, with one tablet, regardless of meals, with water. It is recommended to take it at the same time daily (e.g., in the morning). The recommended dosages are as follows: - 5/20/12.5mg: Administered to patients whose blood pressure is not adequately controlled with combination therapy of Amlodipine/Olmesartan Medoxomil 5/20mg. - 5/40/12.5mg: Administered to patients whose blood pressure is not adequately controlled with combination therapy of Amlodipine/Olmesartan Medoxomil 5/40mg.

Child dose

The safety and efficacy of this medication have not been established in pediatric patients under the age of 18, and administration of this medication is not recommended.

This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. This medication should not be administered to patients with allergies or hypersensitivity history to this drug or its ingredients, pregnant women, nursing mothers, patients with severe hypotension, acute heart failure, or serious renal or hepatic dysfunction. Patients with reduced blood volume or body salt may experience hypotension; therefore, their condition should be carefully monitored before administration, and appropriate measures should be taken if necessary. Patients with compromised renal function or those who have undergone kidney transplantation should have their renal function and electrolyte status checked regularly, and those with renal artery stenosis should also be monitored with caution. Patients with impaired liver function or progressive liver disease should be cautious as this medication may cause hepatic encephalopathy. Patients with heart valve diseases, obstructive coronary artery disease, primary aldosteronism, or systemic lupus erythematosus should also be administered with caution. The diuretic component of this medication may cause electrolyte imbalances, so electrolyte levels should be regularly checked through blood tests. Dizziness or drowsiness may occur during the use of this medication, so it is advisable to avoid driving or operating hazardous machinery. This medication can interact with other drugs, particularly lithium, nonsteroidal anti-inflammatory drugs (NSAIDs), and other antihypertensives; consultation with a physician or pharmacist is recommended. In case of overdose, hypotension, palpitations, and in severe cases, heart function decline may occur, necessitating immediate medical assistance. The safety and efficacy of this medication in children have not been established, and elderly patients should start with a lower dose considering renal or hepatic function declines.

Serious side effects

Hives, severe swelling (edema), difficulty breathing, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden and severe headache, seizures, confusion, visual disturbances, paralysis, significantly decreased urine output, severe systemic edema and increased blood pressure, anaphylactic reactions, jaundice (cholestatic jaundice), Stevens-Johnson syndrome, Quincke's edema, thrombosis

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory tract infections
• nasopharyngitis
• urinary tract infections
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication is sensitive to air and moisture, so it should be stored in a sealed container. The storage temperature should ideally be maintained at room temperature between 1 and 30 degrees Celsius. Proper storage ensures the drug's efficacy and safety are preserved for longer.

Appearance

Light yellow round film-coated tablet

Package unit

28 tablets (14 tablets/PTPX2) / Carton